Abstract
Subclinical hypothyroidism (SCH) was reported to be associated with atherosclerosis (AS) in recent studies. Thyroid hormone levels are normal in patients with SCH, but the levels of thyroid-stimulating hormone (TSH) are increased. Thyroid-stimulating hormone receptor (TSHR) in extra-thyroidal tissues plays a pathophysiological role in these conditions. Our previous results demonstrated that TSHR was functional in hepatocytes and revealed elevated total cholesterol levels in the serum, which were an independent risk factor for AS. TSHR is expressed in vascular smooth muscle cells (VSMCs), and VSMC proliferation plays an important role in the development of AS. Cell proliferation was measured by the MTT assay. Intracellular cyclic AMP (cAMP) was measured using a cAMP ELISA kit. Cells were analyzed using a flow cytometer to determine the cell-cycle phase of each cell. For the purpose of detecting cyclin A and cyclin D, immunohistochemical staining and western blots were performed. Real-time PCR was used to assess the VSMC phenotypes. TSH increased cell progression into the G2/M phases and induced VSMC proliferation; thus, functional TSHR was present on VSMCs. Furthermore, the expression of cyclin D1 and cyclin A was increased. In addition, the results indicated that VSMCs undergo a phenotypic transformation from a contractile state to a synthetic state after treatment with different concentrations of TSH. Elevated TSH can promote VSMC proliferation through the cAMP-dependent pathway.
Similar content being viewed by others
References
G.J. Kahaly, W.H. Dillmann, Thyroid hormone action in the heart. Endocr. Rev. 26(5), 704–728 (2005)
T. Ichiki, Thyroid hormone and atherosclerosis. Vascul. Pharmacol. 52, 151–156 (2010)
I. Klein, S. Danzi, Thyroid disease and the heart. Circulation 116, 1725–1735 (2007)
G. Da Xiang, L.W. Xiang, H.L. He, L.S. Zhao, Post prandial lipaemia suppresses endothelium-dependent arterial dilation in patients with hypothyroidism. Endocrine 42, 391–398 (2012)
E. Cebeci, F.A. Oner, M. Usta, S. Yurdakul, M. Erguney, Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism. Acta Biomed. 82, 214–222 (2011)
L.B. Yang, D.Q. Jiang, W.B. Qi, T. Zhang, Y.L. Feng, L. Gao, J. Zhao, Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies. Eur. J. Endocrinol. 167, 75–84 (2012)
G. Csaba, E. Pallinger, Thyrotropic hormone (TSH) regulation of triiodothyronine (T3) concentration in immune cells. Inflamm. Res. 58, 151–154 (2009)
M. Nannipieri, F. Cecchetti, M. Anselmino, S. Camastra, P. Niccolini, M. Lamacchia, M. Rossi, G. Iervasi, E. Ferrannini, Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int. J. Obes. 33, 1001–1006 (2009)
K.A. Heemstra, W.M. van der Deure, R.P. Peeters, N.A. Hamdy, M.P. Stokkel, E.P. Corssmit, J.A. Romijn, T.J. Visser, J.W. Smit, Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma. Eur. J. Endocrinol. 159, 69–76 (2008)
W. Zhang, L.M. Tian, Y. Han, H.Y. Ma, L.C. Wang, J. Guo, L. Gao, J.J. Zhao, Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcription. J. Cell. Mol. Med. 13, 4636–4642 (2009)
L. Tian, Y. Song, M. Xing, W. Zhang, G. Ning, X. Li, C. Yu, C. Qin, J. Liu, X. Tian, X. Sun, R. Fu, L. Zhang, X. Zhang, Y. Lu, J. Zou, L. Wang, Q. Guan, L. Gao, J.J. Zhao, A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway. Hepatology 52(4), 1401–1409 (2010)
D.F. Sellitti, D. Dennison, T. Akamizu, S.Q. Doi, L.D. Kohn, H. Koshiyama, Thyrotropin regulation of cyclic adenosinemonophosphate production in human coronary artery smooth muscle cells. Thyroid 10, 219–225 (2000)
A.R. Yoo, S.H. Koh, G.W. Cho, S.H. Kim, Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway. J. Atheroscler. Thromb. 17, 1009–1018 (2010)
G.J. Song, N. Fiaschi-Taesch, A. Bisello, Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells. Mol. Endocrinol. (Baltimore, Md.) 23, 1681–1690 (2009)
K. Yokouchi, Y. Numaguchi, R. Kubota, M. Ishii, H. Imai, R. Murakami, Y. Ogawa, T. Kondo, K. Okumura, D.E. Ingber, T. Murohara, l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty. Arterioscler. Thromb. Vasc. Biol. 26(10), 2231–2237 (2006)
R. Zargham, Preventing restenosis after angioplasty: a multistage approach. Clin. Sci. (Lond). 114(4), 257–264 (2008)
Qifeng. Jiang, Renjian. Huang, Shaoxi. Cai, C.L. Wang, Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability. J. Biomed. Sci. 17, 6 (2010)
D.N. Atochin, P.L. Huang, Endothelial nitric oxide synthase transgenic models of endothelial dysfunction. Pflugers Arch. 460(6), 965–974 (2010)
R. Napoli, V. Apuzzi, G. Bosso, C. D’Anna, A. De Sena, C. Pirozzi, A. Marano, G.A. Lupoli, G. Cudemo, U. Oliviero, Recombinant human thyrotropin enhances endothelial-mediated vasodilation of conduit arteries. J. Clin. Endocrinol. Metab. 94(3), 1012–1016 (2009)
R. Napoli, B. Biondi, V. Guardasole, C. D’Anna, A. De Sena, C. Pirozzi, D. Terracciano, C. Mazzarella, M. Matarazzo, L. Sacca, Enhancement of vascular endothelial function by recombinant human thyrotropin. J. Clin. Endocrinol. Metab. 93(5), 1959–1963 (2008)
A. Haribabu, V.S. Reddy, C. Pallavi, A.R. Bitla, A. Sachan, P. Pullaiah, V. Suresh, P.V. Rao, M.M. Suchitra, Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Endocrine 44, 152–157 (2013)
P. Agretti, G. De Marco, M. De Servi, C. Marcocci, P. Vitti, A. Pinchera, M. Tonacchera, Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. Eur. J. Endocrinol. 152, 777–784 (2005)
T.T. Antunes, A. Gagnon, A. Bell, A. Sorisky, Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP-protein kinase A pathway. Obes. Res. 13, 2066–2071 (2005)
H. Guo, N. Makarova, Y. Cheng, E. Shuyu, R.R. Ji, C. Zhang, P. Farrarc, G. Tigyia, The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid. Biochim. Biophys. Acta 1781(9), 571–581 (2008)
E.M. Rzucidlo, Signaling pathways regulating vascular smooth muscle cell differentiation. Vascular 17(Suppl 1), S15–S20 (2009)
R.E. Clempus, D. Sorescu, A.E. Dikalova, L. Pounkova, P. Jo, G.P. Sorescu, B. Lassègue, K.K. Griendling, Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27(1), 42–48 (2007)
C.L. Wang, Caldesmon and the regulation of cytoskeletal functions. Adv. Exp. Med. Biol. 644, 250–272 (2008)
E.S. Park, J.M. Yoo, Y. Lim, M. Tudev, H.S. Yoo, J.T. Hong, Y.P. Yun, Inhibitory effects of docetaxel on platelet-derived growth factor (PDGF)-BB-induced proliferation of vascular smooth muscle cells through blocking PDGF-receptor beta phosphorylation. J. Pharmacol. Sci. 116(2), 204–213 (2011)
Acknowledgments
We thank the teachers in the central laboratory of the first hospital of Lanzhou University for their excellent technical assistance. This research was funded by grants from the National Natural Science Foundation of China (81160100) and the Health Planning Project of Gansu Province (GSWST2011-01).
Author information
Authors and Affiliations
Corresponding author
Additional information
Limin Tian and Jing Ni contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tian, L., Ni, J., Guo, T. et al. TSH stimulates the proliferation of vascular smooth muscle cells. Endocrine 46, 651–658 (2014). https://doi.org/10.1007/s12020-013-0135-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0135-4